• ADT and cardiac risks (and how I sold my company for $1.4bn)

  • Apr 2 2024
  • Length: 32 mins
  • Podcast

ADT and cardiac risks (and how I sold my company for $1.4bn) By cover art

ADT and cardiac risks (and how I sold my company for $1.4bn)

Listen for free

View show details

  • Summary

  • Professor Neil Fleshner (University of Toronto) drops into the GU Cast studio in Melbourne for an intriguing discussion! First we cover off the underrated topic of cardiac risks in patients starting androgen deprivation therapy and how we can reduce these for the benefit of our patients. Then we talk to Neil about entrepreneurship and his journey into very successful business ventures in recent years. He has some inspiring stories and some great advice for frustrated clinicians out there!
    This episode is a Themed Podcast supported by our Bronze Partners, Cipla Australia.

    Even better on our YouTube channel
    Show more Show less
Physical Illness & Disease Hygiene & Healthy Living Science
Show more Show less

What listeners say about ADT and cardiac risks (and how I sold my company for $1.4bn)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available